Gala vs SnagRx: Which GLP-1 Provider Is Better?
Short answer: Gala scores higher on our rubric, 7.2/10 against 3.9/10. Full reasoning, pricing and the cases where the other one wins are below.
Gala beats SnagRx overall, scoring 7.2/10 vs 3.9/10. Published pricing is not a like-for-like monthly comparison: Gala is from $149/mo; SnagRx is published $69/mo; total not verified. Choose Gala for tirzepatide-first patients who want a lower yearly-plan rate (microdose $149/mo or full-dose $179/mo) plus a dedicated ios + android tracker app for daily progress logging. Choose SnagRx for people comparing the lowest published compounded-semaglutide medication floor who will verify the consultation fee and complete total before paying a brand-new storefront with no independent review record.
A side-by-side look at Gala and SnagRx to help you decide. We compare them on:
- •Starting price per month
- •Our overall score, out of 10
- •Medication type, brand-name or compounded
- •Whether they accept insurance
- •Who each one is best for
Gala
#34 of 54Telehealth platform focused on compounded tirzepatide, both microdose and full-dose tiers, alongside a brand-name semaglutide (Ozempic) path and a 'coming soon' Wegovy pill. Operated by AI Coaching, Inc. (Wilmington, DE), backed by OpenLoop-affiliated medical groups (a recognized US telehealth backend) and LegitScript verified. Differentiator: a dedicated 'Gala GLP-1 Tracker' iOS + Android app for in-treatment dosing, weight, and side-effect logging.
Visit GalaSnagRx
#53 of 54SnagRx is a cash-pay compounded GLP-1 storefront operated by Modern Metabolic Medicine, Inc., the same company behind Embody and RodeoMeds. It advertises compounded semaglutide at $69/mo against a $299 regular price and compounded tirzepatide at $119 against $399, but its terms refer to non-refundable medical consult fees, so those are medication floors rather than verified all-in totals. Shipping is free at a stated 1-2 days. Prescriptions are filled through named partner pharmacies including RedRock Pharmacy. The site launched in January 2026 and its Trustpilot profile, though claimed, still carries no reviews.
Visit SnagRx| Feature | Gala | SnagRx |
|---|---|---|
| Our Score | 7.2/10 | 3.9/10 |
| Headline Price | from $149/mo | published $69/mo; total not verified |
| Medication Type | Both | Compounded |
| Insurance Accepted | No | No |
| Best For | Tirzepatide-first patients who want a lower yearly-plan rate (microdose $149/mo or full-dose $179/mo) plus a dedicated iOS + Android tracker app for daily progress logging | People comparing the lowest published compounded-semaglutide medication floor who will verify the consultation fee and complete total before paying a brand-new storefront with no independent review record |
| Watch out for | Brand-name Ozempic here is $1,299/mo, materially above NovoCare's Wegovy pen $199/mo for the first two 0.25 mg or 0.5 mg fills through December 31, 2026, then $349/mo at standard strengths or $399/mo for Wegovy HD; oral pill from $149/mo, dose-dependent and Hims/Hers pill medication from $149 or pen from $199 plus required membership. Buy brand-name elsewhere; Gala's value is its compounded tirzepatide. | No independent review record at all. The Trustpilot profile is claimed and shows zero reviews, so the '125k+ Happy Customers' homepage claim cannot be verified anywhere |
| Ranking | #34 | #53 |
| Get started | Visit Gala | Visit SnagRx |
Pros & Cons Compared
Gala
Pros
- +Compounded tirzepatide is $149/mo microdose or $179/mo full-dose on the yearly plan; 3-month pricing is $169/mo microdose or $219/mo full-dose
- +Dedicated 'Gala GLP-1 Tracker' on BOTH iOS and Android, first-party in-treatment logging is uncommon among compounded-only platforms
- +OpenLoop-affiliated medical groups + LegitScript verification provide third-party accountability that many compounded-only platforms lack
- +All 50 states, free shipping, no insurance required, 24/7 patient support claimed
Cons
- −Brand-name Ozempic here is $1,299/mo, materially above NovoCare's Wegovy pen $199/mo for the first two 0.25 mg or 0.5 mg fills through December 31, 2026, then $349/mo at standard strengths or $399/mo for Wegovy HD; oral pill from $149/mo, dose-dependent and Hims/Hers pill medication from $149 or pen from $199 plus required membership. Buy brand-name elsewhere; Gala's value is its compounded tirzepatide.
- −Tirzepatide-only on the compounded side, compounded semaglutide is NOT offered, a narrower medication menu than peers like Maximus, Ro, or Henry Meds
- −Mixed Trustpilot reviews mention dosing inconsistencies and slow customer service responsiveness, verify your specific dose and batch with each refill
- −Initial consultation is typically a sync video visit, but ongoing follow-ups are chat-based (no scheduled ongoing video access), and there are no published labs, no named medical director, no specialty obesity oversight
- −Restrictive refund policy, Gala's published terms state 'IN NO EVENT SHALL YOU BE ISSUED A REFUND UPON CANCELLATION OF THE SUBSCRIPTION SERVICES' with a narrow exception for provider-initiated medical disqualification. No money-back guarantee. Read the published policy at galaglp1.com/refund-policy before enrolling on a commitment plan
- −Newer brand under AI Coaching, Inc. (founded 2024 per LinkedIn), limited public company history; founders, founding year, and named medical director not publicly disclosed on galaglp1.com itself
SnagRx
Pros
- +The lowest advertised compounded-semaglutide medication floor on this site at $69/mo, if the promotional rate holds; the consultation fee and all-in total remain unresolved
- +Names its partner pharmacy publicly with a link (RedRock Pharmacy), which most competitors do not do
- +Free 1-2 day shipping with a stated one-day turnaround from intake to a written prescription
- +The site markets a locked medication rate with no monthly membership and publishes a separate refund policy; its terms still leave a possible medical consult fee unresolved
- +States service in all 50 states plus Washington D.C.
Cons
- −No independent review record at all. The Trustpilot profile is claimed and shows zero reviews, so the '125k+ Happy Customers' homepage claim cannot be verified anywhere
- −The $69 price sits under a countdown timer that is a standing feature of the page rather than a dated deadline, next to a 'locked-in for life' claim. The regular price is $299
- −'Cancel Anytime' appears three times on the homepage, but the terms say cancellation deadlines 'will be disclosed at checkout or in your account'. A deadline you only see after committing is not cancel-anytime
- −'No Hidden Fees' is contradicted by the terms, which refer to medical consult fees that are not refundable
- −All sales are final once medication is dispensed; refunds are limited to medication not yet shipped where a provider finds you ineligible
- −No named clinicians, no medical director, no published lab or video-visit detail
- −Shares its operating entity with Embody and RodeoMeds. Neither SnagRx nor Embody discloses the relationship on its own site, so a shopper comparing them would not know they are one company
- −Cash-pay only, no insurance billing and no prior-authorisation help
Our Verdict
Gala edges out SnagRx with a score of 7.2/10 vs 3.9/10. Published pricing is not a like-for-like monthly comparison: Gala is from $149/mo; SnagRx is published $69/mo; total not verified. Gala offers both brand-name and compounded medications, giving you more flexibility.
Read Full Reviews
Related comparisons
More head-to-head comparisons involving Gala and SnagRx.
- Gala vs Trimi Health$175/mo month-to-month
- Gala vs Ro$149/mo membership + medication
- Gala vs Mochi Healthfrom $178/mo
- SnagRx vs Foundpublished $129/mo; total not verified
- SnagRx vs Oak Longevityfrom $119/mo
- SnagRx vs Fridays$249/mo month-to-month
Not sure which one is right for you?
Answer a few quick questions and we'll match you to the best GLP-1 provider for your needs. Or keep exploring below.
Our pick of these two: Gala · 7.2/10